| Target Validation Information | |||||
|---|---|---|---|---|---|
| TTD ID | T51843 | ||||
| Target Name | Virus RNA-dependent RNA polymerase (Viru RdRP) | ||||
| Type of Target |
Clinical trial |
||||
| Drug Potency against Target | Favipiravir | Drug Info | IC50 = 140 nM | [2] | |
| Action against Disease Model | Favipiravir | Drug Info | T-705 showed IC50 values of less than 0.5 |?g/ml in virus yield assays in MDCK cells against all three influenza virus types (A, B, C) with no signs of cytotoxicity. | [1] | |
| References | |||||
| REF 1 | In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother. 2002 Apr;46(4):977-81. | ||||
| REF 2 | Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother. 2005 Mar;49(3):981-6. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.